Clinical Trials Directory

Trials / Unknown

UnknownNCT04780243

Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization

Enhancing Postpartum Family Planning Utilization Through Integration With Expanded Program for Immunization in Sidama, South Ethiopia: A Quasi Experimental Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,474 (estimated)
Sponsor
Hawassa University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This study is aimed to enhance postpartum family planning by integrating family planning information with infant immunization services, which is the most widely utilized health services globally.

Detailed description

In this study, a before-and-after type of quasi-experimental study will be conducted in purposely selected health centers Sidama region, Ethiopia. base line assessment of postpartum contraceptive utilization rate will be done which will be followed by an intervention. The intervention consists of screening, counseling for family planning and referring mothers coming for infant immunization services to family planning units. All mothers coming for infant immunization service will be screened for and counseled for family planning and those who will be voluntary to take any method will be referred to family planning unit. All mothers who will not be voluntary will be re-counseled by the next visit. Finally, the effect of this intervention on postpartum contraceptive utilization rate will be reassessed. The expected outcome will be to see an improved contraceptive uptake during the first year after delivery.

Conditions

Interventions

TypeNameDescription
OTHERcounselingMothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services

Timeline

Start date
2020-02-01
Primary completion
2020-08-30
Completion
2021-03-17
First posted
2021-03-03
Last updated
2021-03-03

Locations

1 site across 1 country: Ethiopia

Source: ClinicalTrials.gov record NCT04780243. Inclusion in this directory is not an endorsement.